Philadelphia, PANCT05377216Now EnrollingIRB Ready

Ventricular Tachycardia Clinical Trial in Philadelphia, PA

Access cutting-edge ventricular tachycardia treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by University of Pennsylvania

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions…

Expert Care in Philadelphia

Access ventricular tachycardia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ventricular tachycardia treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this ventricular tachycardia clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This Ventricular Tachycardia Study in Philadelphia

Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.

Sponsor: University of Pennsylvania

Who Can Participate

Inclusion Criteria

Planned catheter based VT ablation
Age at least 18 years

Exclusion Criteria

Contraindication to SGB or VT ablation
Hypersensitivity of local anesthetic of amide type
Hemodynamic instability during the procedure prior to the study protocol

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT05377216) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ventricular Tachycardia Treatment Options in Philadelphia, PA

If you're searching for ventricular tachycardia treatment options in Philadelphia, PA, this clinical trial (NCT05377216) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ventricular tachycardia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ventricular tachycardia clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in Philadelphia, PA

See all interstitial cystitis clinical trials recruiting in Philadelphia — not just this study.

Browse Interstitial Cystitis Trials in Philadelphia

Browse More Trials by Condition

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Philadelphia, PA